Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Circumferential vs non-circumferential mepivacaine distribution for median and ulnar nerve block in carpal tunnel surgery
2011-002608-34Phase 4Completed
- Sponsor
- Paula Diéguez GarcÃa
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mepivacaine in carpal tunnel syndrome (CTS) (2 arms), sponsored by Paula Diéguez GarcÃa. Primary endpoints: Efficacy of median and ulnar nerve block and Onset of median and ulnar nerve block. Started Oct 2011; status: completed.
02
Drugs
mepivacaine
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on 2011-002608-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002608-34.